Showing 341-360 of 503 for: Cochrane Systematic Reviews > Neurologic
- Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 13-Nov-2008
Long-term levodopa therapy in Parkinson's disease is associated with the development of motor complications including abnormal involuntary movements and a shortening response to each dose (wearing off phenomenon). It is thought that dopamine agonists can
- Pharmacological interventions for epilepsy in people with intellectual disabilities
Cochrane Systematic Reviews, 2-Sep-2015
The prevalence of epilepsy among people with intellectual disabilities is much higher than in the general population. Seizures in this population are often complex and refractory to treatment and antiepileptic medication may have a profound effect upon be
- Pharmacological interventions for spasticity following spinal cord injury
Cochrane Systematic Reviews, 28-Jul-2009
Spasticity is a major health problem for patients with a spinal cord injury (SCI). It limits their mobility and affects their independence in activities of daily living (ADL) and work. Spasticity may also cause pain, loss of range of motion, contractures,
- Pharmacological management for agitation and aggression in people with acquired brain injury
Cochrane Systematic Reviews, 13-May-2008
Of the many psychiatric symptoms that may result from brain injury, agitation and/or aggression are often the most troublesome. It is therefore important to evaluate the efficacy of psychotropic medication used in its management.
- Pharmacological treatment for aphasia following stroke
Cochrane Systematic Reviews, 23-Mar-2010
Aphasia describes language impairment associated with a brain lesion.
- Pharmacological treatment for Kleine-Levin syndrome
Cochrane Systematic Reviews, 7-Aug-2013
This is an updated version of the original Cochrane review, published in Issue 2, 2009.
- Pharmacological treatment for memory disorder in multiple sclerosis
Cochrane Systematic Reviews, 16-Dec-2013
This is an update of the Cochrane review "Pharmacologic treatment for memory disorder in multiple sclerosis" (first published in The Cochrane Library 2011, Issue 10).
- Pharmacological treatments for fatigue associated with palliative care
Cochrane Systematic Reviews, 11-Jun-2015
This review updates the original review, 'Pharmacological treatments for fatigue associated with palliative care' and also incorporates the review 'Drug therapy for the management of cancer-related fatigue'.
- Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures
Cochrane Systematic Reviews, 29-Nov-2012
This is an updated version of the original Cochrane review published in The Cochrane Library 2001, Issue 4.
- Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures
Cochrane Systematic Reviews, 13-Aug-2013
This is an updated version of the previously published Cochrane review (Issue 4, 2009)
- Physical exercise for sleep problems in adults aged 60+
Cochrane Systematic Reviews, 11-Nov-2008
The prevalence of sleep problems in adulthood increases with age. While not all sleep changes are pathological in later life, severe disturbances may lead to depression, cognitive impairments, deterioration of quality of life, significant stresses for car
- Physical fitness training for stroke patients
Cochrane Systematic Reviews, 21-Mar-2016
Levels of physical fitness are low after stroke. It is unknown whether improving physical fitness after stroke reduces disability.
- Physical methods versus drug placebo or no treatment for managing fever in children
Cochrane Systematic Reviews, 17-Feb-2009
Health workers recommend bathing, sponging, and other physical methods to treat fever in children and to avoid febrile convulsions. We know little about the most effective methods or how these methods compare with commonly used drugs.
- Physiotherapy for Parkinson's disease: a comparison of techniques
Cochrane Systematic Reviews, 13-May-2014
Despite medical therapies and surgical interventions for Parkinson's disease (PD), patients develop progressive disability. The role of physiotherapy is to maximise functional ability and minimise secondary complications through movement rehabilitation wi
- Physiotherapy versus placebo or no intervention in Parkinson's disease
Cochrane Systematic Reviews, 17-Jun-2013
Despite medical therapies and surgical interventions for Parkinson's disease (PD), patients develop progressive disability. Physiotherapy aims to maximise functional ability and minimise secondary complications through movement rehabilitation within a con
- Physostigmine for dementia due to Alzheimer's disease
Cochrane Systematic Reviews, 1-Jun-2008
The main pharmacological approach for the treatment of Alzheimer's disease (AD) has been based on the use of agents potentiating cholinergic transmission, particularly by inhibiting acetylcholinesterase (AChE), the enzyme that destroys acetylcholine after
- Pimozide for tics in Tourette's syndrome
Cochrane Systematic Reviews, 17-Feb-2009
Neuroleptic drugs with potent D-2 receptor blocking properties have been the traditional treatment for tics caused by Tourette Syndrome. Pimozide is the most studied of these. Use of these medications is declining because of concerns about side effects, a
- Piracetam for dementia or cognitive impairment
Cochrane Systematic Reviews, 6-Jan-2012
Piracetam is a drug that may enhance memory and other intellectual functions, but its usefulness in treating dementia is uncertain. It is, however, commonly prescribed for cognitive impairment and dementia in several countries of continental Europe.
- Placebo interventions for all clinical conditions
Cochrane Systematic Reviews, 11-Nov-2009
Placebo interventions are often claimed to substantially improve patient-reported and observer-reported outcomes in many clinical conditions, but most reports on effects of placebos are based on studies that have not randomised patients to placebo or no t
- Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 17-Aug-2015
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an uncommon progressive or relapsing paralysing disease caused by inflammation of the peripheral nerves. If the hypothesis that it is due to autoimmunity is correct, removal of autoantibo